期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

新生儿溶血病患儿血浆组织因子和组织因子途径抑制物含量的变化 被引量：1

原文传递
导出
作者 岳少杰 王铭杰 刘霜 钟乐 何晓凡 杨于嘉 姜玲 贺石林 李俊成
机构地区 中南大学湘雅医院儿科 中南大学湘雅医学院生理教研室
出处 《中华围产医学杂志》 CAS 2006年第6期423-424,共2页 Chinese Journal of Perinatal Medicine
基金 国家自然科学基金资助项目(39770710 39830180)
关键词 新生儿溶血病患儿 血浆组织因子 制物含量 症状
分类号 R722.1 [医药卫生—儿科]
  • 相关文献

参考文献10

  • 1Hack CE.Tissue factor pathway of coagulation in sepsis.Crit Care Med,2000,28:S25-30.
  • 2Chan JC.Gene targeting in hemostasis.tissue factor pathway inhibitor.Front Biosci,2001,6:D216-221.
  • 3Bajaj MS,Birktoft JJ,Steer SA,et al.Structure and biology of tissue factor pathway inhibitor.Thromb Haemost,2001,86:959-972.
  • 4王慕逖 主编.儿科学:第5版[M].,2001.97.
  • 5Sandset PM,Warn-Cramer BJ,Rao LV,et al.Depletion of extrinsic pathw ay inhibitor(EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor:evidence supporting a physiologic role for EPI as a natural anticoagulant.Proc Natl Acad Sci U S A,1991,88:708-712.
  • 6Camerota AJ,Creasey AA,Patla V,et al.Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitis.J Infect Dis,1998,177:668-676.
  • 7Cvirn G,Gallistl S,Rehak T,et al.Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma.J Thromb Haemost,2003,1:1785-1790.
  • 8Cvirn G,Gallistl S,Leschnik B,et al.Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates.J Thromb Haemost,2003,1:263-268.
  • 9Siddiqui FA,Francis JL.Hemoglobin binds melanoma cell tissue factor and enhances its procoagulant activity.Blood Coagul Fibrinolysis,2002,13:173-180.
  • 10Siddiqui FA,Amirkhosravi A,Amaya M,et al.Hemoglobin enhances tissue factor expression on human malignant cells.Blood Coagul Fibrinolysis,2001,12:171-177.

共引文献42

同被引文献20

  • 1王惠良,邓海松,赵晓静,蔡丽娅.新生儿ABO溶血病的早期护理干预[J].护士进修杂志,2006,21(11):1022-1023. 被引量：13
  • 2Saxena R. Neonatal thrombosis. Indian-J-Pediatr,2003 ,70 :903.
  • 3Borrelli AL, De Lucia D, Bcmacchi M, et al. Haemocoagnlative modifications correlated with pregnancy. Minerva Ginccol,2006,58:315-322.
  • 4Nordenhem A, Wiman B. Tissue plasminogen activator (tPA) antigen in plasma: corelation with different tPA/inhibitor complexes. Scand J Clin Lab Invest, 1998,58:475.
  • 5Deepa R, Velmurugan K, Saravanan G, et al. Relationship otissue plasminogen activator,plasminogen activator inhibitor and fibrinogen with coronary artery disease in South India male subjects. J Assoc Physicians India ,2002,50:901-906.
  • 6Levi M. Current understanding of disseminated intravascular co-agulation. Br J Haematol,2004 ,124 :567-576.
  • 7Fay WP, Parker AC, Condrey LR, et al. Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. Blood, 1997,90:204.
  • 8Masson C, Angles Cano E. Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator. Biochem J, 1988,256:237.
  • 9Levi M, de Jonge E, van der Poll T. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med ,2001,29 : $90-$94.
  • 10Elisdbeth M, Annie P. VitaminK in neonates. Paediatric Drugs, 2001,3 : 1-8.

二级引证文献5

中华围产医学杂志
2006年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部